Cargando…

Universal coronavirus vaccine; spike protein cloning and expression for use as a recombinant vaccine

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 1994
Materias:	Patent Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131693/ http://dx.doi.org/10.1016/0264-410X(94)90279-8

Ejemplares similares

Plasmodium Duffy receptor protein; Plasmodium knowlesi or Plasmodium vivax gene cloning and expression; potential recombinant vaccine against malaria; DNA sequence
Publicado: (1992)

Nucleic acid constructs, malaria polypeptides and vaccines; recombinant malaria serine-repeat antigen production in yeast for the construction of a recombinant vaccine
Publicado: (1992)

New dengue virus Type-1 strain; recombinant DEN1 protein expression; potential in recombinant vaccine construction, virus detection and dengue fever diagnosis and therapy
Publicado: (1994)

Nematode protein complex; Haemonchus contortus immunogen and anthelmintic agent; protein sequence; recombinant vaccine production
Publicado: (1991)

cDNA clone of non-A non-B hepatitis virus (NANB) post transfusion and its use — DNA sequence; potential application as recombinant vaccine; DNA probe application in disease diagnosis
Publicado: (1991)

Non-infective structural particle preparation containing flavivirus surface antigen protein; Japanese-encephalitis virus cDNA gene cloning in dengue virus-2-preinfected cell with a vaccinia virus vector and use of a non-infective structural particle as recombinant vaccine
Publicado: (1994)

Recombinant Pseudomonas exotoxin produced by cloning of Pseudomonas aeruginosa DNA in Escherichia coli having low toxicity to human or mice cells but retaining enzymatic activity giving cell-specific immunotoxin; vaccine application
Publicado: (1988)

Synthetic peptide antigen corresponding to the major sites of T-lymphocyte recognition within the HIV virus envelope protein: recombinant vaccine production
Publicado: (1989)

New epitope-bearing portions of Entamoeba histolytica; recombinant non-glycosylated epitope production and expression in prokaryote host cell, for application in a recombinant vaccine : Univ. Virginia Pat. Found. World 9500 849; 5 January 1995
Publicado: (1995)

New DNA sequences of Epstein-Barr virus genome useful in protein expression for viral antibody detection in blood serum, for vaccine production and as DNA probe
Publicado: (1986)

Heterologous virus peptide immunogen production: recombinant vaccine production in L-cell, Chinese hamster ovary, C127 cell culture
Publicado: (1989)

Gene encoding H-protein of sclerosing-panencephalitis virus, a potential vaccine
Publicado: (1989)

Preparation of cholera toxin subunit-B for use in vaccine preparation
Publicado: (1986)

Preparation of a helicase region coded by hepatitis C virus; hepatitis C virus recombinant helicase production via gene cloning and expression in Spodoptera frugiperda insect cell culture using baculovirus vector : Soyaku Eng. Res. Inst. Jpn 06319 583; 22 November 1994
Publicado: (1995)

Envelope region nucleic acid fragment of type-C hepatitis virus and its detection; diagnosis using hepatitic C virus DNA probe or RNA probe; DNA sequence; potential recombinant vaccine preparation
Publicado: (1993)

Antigens of Cysticercus cellulosae; used for antibody production, treatment of neurocysticercosis, diagnosis or vaccine production
Publicado: (1991)

Bordetella pertussis coding sequences used for producing polypeptides that retain immunogenicity but lack virulence for vaccine production
Publicado: (1989)

Antigen specific to non-A, non-B hepatitis virus: application for vaccine production
Publicado: (1987)

New avirulent Salmonella-Escherichia coli hybrid strains useful in live oral vaccine against enteric diseases including cholera
Publicado: (1988)

Vaccine against Schistosoma mansoni containing soluble antigen from larvae or adults
Publicado: (1986)

Inactivated pigeon herpes virus vaccine from chicken fibroblast cell culture
Publicado: (1986)

Strain-independent inactivated influenza vaccine production by removal of the hemagglutinin heavy HA1 chain
Publicado: (1986)

Ringworm vaccine; containing antigen from e.g. Microsporum canis, Microsporum gypsum or Trichophyton mentagrophytes
Publicado: (1991)

Canine parvovirus vaccine preparation by growth of CPV-HP stem on dog tumour fibroblasts or renal cells
Publicado: (1988)

Vaccine for immunizing cattle against lungworm comprising live immunogenic attenuated Dictyocaulus viviparus third stage larvae
Publicado: (1988)

New vaccine against infectious viruses — e.g. feline infectious-peritonitis virus, providing cell-mediated immunity
Publicado: (1991)

Vaccine against feline infectious peritonitis virus is prepared from virus FIPV 79-1146 serially passaged in non-oncogenic cell until nonvirulent
Publicado: (1988)

Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses
Publicado: (1992)

Recent Patents of Interest to Dentists
Publicado: (1907)

Expired Patents
Publicado: (1907)

Recent Patents of Interest to Dentists
Publicado: (1907)

Expired Patents
Publicado: (1907)

Expired Patents
Publicado: (1907)

Patents of Interest to Dentists Recently Granted
Publicado: (1907)

Expired Patents
Publicado: (1907)

Expired Patents
Publicado: (1907)

Recent Patents of Interest to Dentists
Publicado: (1907)

Expired Patents
Publicado: (1907)

Recent Patents of Interest to Dentists
Publicado: (1907)

Recent Patents of Interest to Dentists
Publicado: (1907)

Cannot write session to /tmp/vufind_sessions/sess_0qhbdt2q91efhd9ntrj50nj7ab